Fibrosis of pulmonary vascular remodeling in carotid artery-jugular vein shunt pulmonary artery hypertension model of rats

European Journal of Cardio-thoracic Surgery

Volumn 41, Issue 1, 2012, Pages 162-166

  Xiong, Mai ^a   Yao, Jian Ping ^a   Wu, Zhong Kai ^a   Liao, Bing ^a   Liang, Ying Jie ^a   Zhang, Xi ^a   Wang, Zhi Ping ^a  

^a THE FIRST AFFILIATED HOSPITAL OF SUN YAT SEN UNIVERSITY   (China)

Author keywords

Fibrosis hypertension; Pulmonary arterioles; Transforming growth factor beta 1 rat

Indexed keywords

MESSENGER RNA; MONOCROTALINE; TRANSFORMING GROWTH FACTOR BETA1; TRANSFORMING GROWTH FACTOR BETA RECEPTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTERIOLE; ARTERY LIGATION; ARTICLE; CAROTID ARTERY; CAROTID ARTERY JUGULAR VEIN SHUNT; COMMON CAROTID ARTERY; CONTROLLED STUDY; EXTERNAL JUGULAR VEIN; FIBROGENESIS; JUGULAR VEIN; LUNG FIBROSIS; LUNG HEMODYNAMICS; LUNG PARENCHYMA; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PULMONARY HYPERTENSION; RANDOMIZATION; RAT; RECEPTOR UPREGULATION; RESPIRATORY TRACT DISEASE; RIGHT VENTRICULAR SYSTOLIC PRESSURE; STEREOLOGY; SYSTOLIC BLOOD PRESSURE; VEIN ANASTOMOSIS; ANIMAL; ARTERIOVENOUS SHUNT; BIOSYNTHESIS; DISEASE MODEL; FIBROSIS; GENE EXPRESSION REGULATION; GENETICS; HEMODYNAMICS; METABOLISM; METHODOLOGY; PATHOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY; PULMONARY ARTERY; SPRAGUE DAWLEY RAT;

ANIMALS; ARTERIOLES; ARTERIOVENOUS SHUNT, SURGICAL; CAROTID ARTERY, COMMON; DISEASE MODELS, ANIMAL; FIBROSIS; GENE EXPRESSION REGULATION; HEMODYNAMICS; HYPERTENSION, PULMONARY; JUGULAR VEINS; MALE; PULMONARY ARTERY; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, TRANSFORMING GROWTH FACTOR BETA; RNA, MESSENGER; TRANSFORMING GROWTH FACTOR BETA1;

EID: 84860335920     PISSN: 10107940     EISSN: 1873734X     Source Type: Journal    
DOI: 10.1016/j.ejcts.2011.04.031     Document Type: Article

References (25)

1. Humbert M, Morrell NW, Archer SL, Stenmark KR, MacLean MR, Lang IM, Christman BW, Weir EK, Eickelberg O, Voelkel NF, Rabinovitch M. Cellular and molecular pathobiology of pulmonary arterial hypertension. J Am Coll Cardiol 2004;43:13S-24S.
2. Hsu HH, Ko WJ, Hsu JY, Chen JS, Lee YC, Lai IR, Chen CF. Simvastatin ameliorates established pulmonary hypertension through a heme oxyge- nase-1 dependent pathway in rats. Respir Res 2009;10:32.
3. Lang IM, Klepetko W. Chronic thromboembolic pulmonary hypertension: an updated review. Curr Opin Cardiol 2008;23:555-9.
4. Galie N, Manes A, Farahani KV, Pelino F, Palazzini M, Negro L, Romanazzi S, Branzi A. Pulmonary arterial hypertension associated to connective tissue diseases. Lupus 2005;14:713-7.
5. Barst RJ, Abenhaim L. Fatal pulmonary arterial hypertension associated with phenylpropanolamine exposure. Heart 2004;90:e42.
6. Stenmark KR, Fagan KA, Frid MG. Hypoxia-induced pulmonary vascular remodeling: cellular and molecular mechanisms. Circ Res 2006;99: 675-91.
7. Kay JM, Harris P, Heath D. Pulmonary hypertension produced in rats by injection of crotalaria spectabilis seeds. Thorax 1967;22:176-9.
8. Boake WC, Daley R, McMillan IK. Observations on hypoxic pulmonary hypertension. Br Heart J 1959;21:31-9.
9. Miyamoto T, Takeishi Y, Shishido T, Takahashi H, Itoh M, Kubota I, Tomoike H. Role of nitric oxide in progression of cardiovascular remodeling induced by carotid arterio-venous shunt in rabbits. Jpn Heart J 2003;44:127-37.
10. Miniati D. Pulmonary vascular remodeling. Semin Pediatr Surg 2007;16: 80-7.
11. Mandegar M, Fung YC, Huang W, Remillard CV, Rubin LJ, Yuan JX. Cellular and molecular mechanisms of pulmonary vascular remodeling: role in the development of pulmonary hypertension. Microvasc Res 2004;68:75-103.
12. Stenmark KR, McMurtry IF. Vascular remodeling versus vasoconstriction in chronic hypoxic pulmonary hypertension: a time for reappraisal? Circ Res 2005;97:95-8.
13. Rabinovitch M Pathobiology of pulmonary hypertension. Extracellular matrix. Clin Chest Med 2001;22:433-49.
14. Heath D, Ewards J. A description of six grades of structural changes in the pulmonary arteries with special reference to congenital cardiac septal defects. Circulation 1958;18:533-47.
15. Voelkel NF, Cool C. Pathology of pulmonary hypertension. Cardiol Clin 2004;22:343-51.
16. Reindel JF, Ganey PE, Wagner JG, Slocombe RF, Roth RA. Development of morphologic, hemodynamic, and biochemical changes in lungs of rats given monocrotaline pyrrole. Toxicol Appl Pharmacol 1990;106: 179-200.
17. Wedgwood S, Bekker JM, Black SM. Shear stress regulation of endothelial NOS in fetal pulmonary arterial endothelial cells involves PKC. Am J Physiol Lung Cell Mol Physiol 2001;281:L490-8.
18. Barst RJ. PDGF signaling in pulmonary arterial hypertension. J Clin Invest 2005;115:2691-4.
19. Wedgwood S, Devol JM, Grobe A, Benavidez E, Azakie A, Fineman JR, Black SM. Fibroblast growth factor-2 expression is altered in lambs with increased pulmonary blood flow and pulmonary hypertension. Pediatr Res 2007;61:32-6.
20. Liu X, Wei HS, Lin S. Signal transduction of hepatic stellate cells in liver fibrosis. J Med Mol Biol 2006;5:361-3.
21. Cordeiro Mf. Beyond mitomycin: TGF beta and wound healing. Prog Retin Eye Res 2002;21:75-89.
22. Gressner AM, Weiskirchen R. Modern pathogenetic concepts of liver fibrosis suggest stellate cells and TGF-beta as major players and therapeutic targets. J Cell Mol Med 2006;10:76-99.
23. Zhang X, Cui Y, Fang L, Li F. Chronic high-fat diets induce oxide injuries and fibrogenesis of pancreatic cells in rats. Pancreas 2008;37:e31-8.
24. Isaka Y, Tsujie M, Ando Y, Nakamura H, Kaneda Y, Imai E, Hori M. Transforming growth factor-beta 1 antisense oligodeoxynucleotides block interstitial fibrosis in unilateral ureteral obstruction. Kidney Int 2000;58:1885-92.
25. Hooper WC, Mensah GA, Haworth SG, Black SM, Garcia JG, Langleben D. Vascular endothelium summary statement V: pulmonary hypertension and acute lung injury: public health implications. Vascul Pharmacol 2007;46:327-9.